5-MeO-NsBT, also known as 5-methoxy-N-sec-butyltryptamine, is a psychoactive drug of the tryptamine and 5-methoxytryptamine families.[1][2] It emerged as a novel designer drug online in December 2022.[1] More specifically, its chemical synthesis and the claimed properties and effects of 5-MeO-NsBT were posted on a specialized psychoactive drug forum.[1]

The dose of the drug is said to be 3 to 10 mg orally and its onset is said to be 20 to 30 minutes, whereas its duration was not specified.[1] Its effects were reported to include mildly increased empathy and sociability, more fluid thinking, easy and pleasant writing, intoxication, confusion, and after-effects such as mild depression.[1] In addition, possible anti-inflammatory and analgesic effects were reported.[1] No psychedelic or hallucinogenic effects were described.[1]

The drug has not otherwise been encountered, for instance sold online or in drug seizures, as of 2023.[1] It is not a controlled substance in Canada as of 2025.[3]

See also

References

  1. 1 2 3 4 5 6 7 8 9 10 11 "5-MeO-NsBT (5-MeO-N-secbutyltryptamine)". АИПСИН (in Russian). Retrieved 6 January 2026.
  2. ↑ Yurchenko R, Yurchenko L, Pavlovets Y, Galetskaya I (January 2023). "Recent trends in the identification of psychoactive substances". AIPSIN Belarusian Monitoring Platform (in Russian) (37). doi:10.13140/RG.2.2.34396.46722. Retrieved 2 January 2026.
  3. ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
source: https://en.wikipedia.org/wiki/5-MeO-NsBT